Fortress Biotech (FBIO) Competitors $1.57 -0.02 (-1.26%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends FBIO vs. CMRX, ACHV, RGLS, AGEN, SABS, CRIS, BOLT, MTEM, NATR, and AQSTShould you be buying Fortress Biotech stock or one of its competitors? The main competitors of Fortress Biotech include Chimerix (CMRX), Achieve Life Sciences (ACHV), Regulus Therapeutics (RGLS), Agenus (AGEN), SAB Biotherapeutics (SABS), Curis (CRIS), Bolt Biotherapeutics (BOLT), Molecular Templates (MTEM), Nature's Sunshine Products (NATR), and Aquestive Therapeutics (AQST). These companies are all part of the "medical" sector. Fortress Biotech vs. Chimerix Achieve Life Sciences Regulus Therapeutics Agenus SAB Biotherapeutics Curis Bolt Biotherapeutics Molecular Templates Nature's Sunshine Products Aquestive Therapeutics Chimerix (NASDAQ:CMRX) and Fortress Biotech (NASDAQ:FBIO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, valuation, media sentiment, profitability, institutional ownership, risk, dividends and earnings. Does the media favor CMRX or FBIO? In the previous week, Fortress Biotech had 7 more articles in the media than Chimerix. MarketBeat recorded 10 mentions for Fortress Biotech and 3 mentions for Chimerix. Chimerix's average media sentiment score of 0.83 beat Fortress Biotech's score of -0.11 indicating that Chimerix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chimerix 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fortress Biotech 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend CMRX or FBIO? Chimerix presently has a consensus target price of $8.50, indicating a potential upside of 865.91%. Fortress Biotech has a consensus target price of $13.67, indicating a potential upside of 770.49%. Given Chimerix's higher probable upside, equities analysts plainly believe Chimerix is more favorable than Fortress Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Chimerix 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Fortress Biotech 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, CMRX or FBIO? Chimerix has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Comparatively, Fortress Biotech has a beta of 1.75, meaning that its stock price is 75% more volatile than the S&P 500. Do institutionals & insiders hold more shares of CMRX or FBIO? 45.4% of Chimerix shares are owned by institutional investors. Comparatively, 96.5% of Fortress Biotech shares are owned by institutional investors. 13.1% of Chimerix shares are owned by company insiders. Comparatively, 33.4% of Fortress Biotech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community favor CMRX or FBIO? Chimerix received 64 more outperform votes than Fortress Biotech when rated by MarketBeat users. Likewise, 63.68% of users gave Chimerix an outperform vote while only 63.62% of users gave Fortress Biotech an outperform vote. CompanyUnderperformOutperformChimerixOutperform Votes39163.68% Underperform Votes22336.32% Fortress BiotechOutperform Votes32763.62% Underperform Votes18736.38% Which has stronger valuation & earnings, CMRX or FBIO? Fortress Biotech has higher revenue and earnings than Chimerix. Chimerix is trading at a lower price-to-earnings ratio than Fortress Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChimerix$320K247.34-$82.10M-$0.94-0.94Fortress Biotech$84.51M0.51-$60.64M-$3.05-0.51 Is CMRX or FBIO more profitable? Chimerix has a net margin of 0.00% compared to Fortress Biotech's net margin of -84.53%. Fortress Biotech's return on equity of 0.00% beat Chimerix's return on equity.Company Net Margins Return on Equity Return on Assets ChimerixN/A -50.78% -44.94% Fortress Biotech -84.53%N/A -34.93% SummaryFortress Biotech beats Chimerix on 10 of the 17 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Fortress Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for FBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBIO vs. The Competition Export to ExcelMetricFortress BiotechPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$43.33M$6.44B$5.06B$8.82BDividend YieldN/A8.11%5.17%4.07%P/E Ratio-0.5110.79125.9917.81Price / Sales0.51243.721,180.3874.38Price / CashN/A22.1633.8232.53Price / Book15.705.474.684.68Net Income-$60.64M$153.61M$119.54M$226.08M7 Day PerformanceN/A-4.32%-2.45%-2.04%1 Month Performance-11.80%-8.61%-4.06%0.06%1 Year Performance-28.64%28.79%29.86%24.60% Fortress Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBIOFortress Biotech3.0653 of 5 stars$1.57-1.3%$13.67+770.5%-43.9%$43.89M$84.51M-0.51186Analyst ForecastAnalyst RevisionCMRXChimerix4.521 of 5 stars$0.88flat$8.50+865.9%-12.0%$79.14M$320,000.000.0072Analyst ForecastACHVAchieve Life Sciences1.4887 of 5 stars$4.31-0.9%$14.80+243.8%-21.9%$149.25MN/A0.0020RGLSRegulus Therapeutics2.4586 of 5 stars$1.40-1.4%$10.80+671.4%+0.0%$93.01MN/A-1.3130AGENAgenus3.8851 of 5 stars$2.67+3.9%$10.00+274.5%-82.0%$60.29M$156.31M0.00389Analyst RevisionSABSSAB Biotherapeutics3.5154 of 5 stars$3.06-5.6%$12.40+305.2%+267.0%$29.90M$2.24M0.00140CRISCuris2.0186 of 5 stars$3.70-2.4%$23.00+521.6%-56.3%$22.66M$10.02M-0.4749BOLTBolt Biotherapeutics3.3839 of 5 stars$0.57+1.8%$3.50+514.0%-37.7%$21.48M$7.88M0.00100MTEMMolecular Templates2.2363 of 5 stars$0.39-4.9%N/A-92.0%$2.66M$57.31M0.0062Insider TradeNATRNature's Sunshine Products2.7973 of 5 stars$16.00+0.2%$19.00+18.8%-7.5%$295.05M$445.32M18.18814Positive NewsAQSTAquestive Therapeutics2.266 of 5 stars$4.74-1.7%$9.80+107.0%+164.5%$439.48M$50.58M-10.52160Short Interest ↓Positive News Related Companies and Tools Related Companies CMRX Alternatives ACHV Alternatives RGLS Alternatives AGEN Alternatives SABS Alternatives CRIS Alternatives BOLT Alternatives MTEM Alternatives NATR Alternatives AQST Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FBIO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortress Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortress Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
